Previous researches have shown that low serum SHBG is related to obesity, insulin resistance, compensatory hyperinsulinemia, and is a biomarker for abnormal glucose and lipid metabolism, type 2 diabetes, and cardiovascular diseases [49, 50]. Here, SHBG is linked to hyperinsulinism.